17h
Business and Financial Times on MSNUnderstanding Viral Hepatitis: A comprehensive overviewLATIF Viral hepatitis is an inflammation of the liver caused by a viral infection, which can lead to serious health ...
The restructuring is only the latest round of layoffs to hit Arbutus, after the company shed 40% of its staff and cut back on ...
Pune: Infectious disease experts in the city have raised concerns over a sharp rise in gastroenteritis cases, alongside a significant increase in typh.
PATIENTS at hospitals across south Essex are now being automatically screened for HIV and hepatitis when they have a blood ...
18h
AllAfrica on MSNNigeria: Tinubu Launches Campaign to Eliminate HIV/Aids, Syphilis, HepatitisMrs Tinubu referenced data from the Federal Ministry of Health and Social Welfare, which revealed that in 2024, over 100,000 children and nearly two million adults were living with HIV.
"An adversarial collaboration on vaccines could serve as a model," write Drs. Christopher M. Worsham and Anupam B. Jena.
Investors with a lot of money to spend have taken a bearish stance on Gilead Sciences GILD. And retail traders should know.
A Michigan patient died of rabies earlier this year after contracting the virus through an organ transplant, health officials said.
LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation ...
Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Gilead Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results